(3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride, 95.0%, 250mg

1-Methyl-3-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 90.0%, 250mg

1-(TERT-BUTOXYCARBONYL)-3-FLUOROPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 1g

GC capillary column ROTI®Cap-5, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

C8 alkyne dCTP, min. 95%, 100 mM in water, 10 µl, plastic package.

4-(Methylsulfinyl)phenol, 95.0%, 25g

4-(4'-BROMO-PHENYL)PIPERIDINE HYDROCHLORIDE, 97.0%, 25g

(+/-)-Phenyl(pyridin-2-yl)methanol>98.0%(GC)5g

2-o-Tolyloxy-ethylamine, 95.0%, 5g

Inhibitor Cocktail Standard

N-METHOXY-N-METHYL-1-(TRIFLUOROMETHYL)CYCLOPROPANECARBOXAMIDE, 95.0%, 500mg

3-(2-HYDROXYETHYL)PYRROLIDIN-2-ONE, 95%, 100mg

3-NITRO-4-((TETRAHYDRO-2H-PYRAN-4-YL)METHYLAMINO)BENZENESULFONAMIDE, 95.0%, 500g